α1β2δ, a silent GABAA receptor: Recruitment by tracazolate and neurosteroids

British Journal of Pharmacology

Volumn 153, Issue 5, 2008, Pages 1062-1071

  Zheleznova, N ^a   Sedelnikova, A ^a   Weiss, D S ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Neurosteroid THDOC; Tracazolate

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; RECEPTOR SUBUNIT; TETRAHYDRODEOXYCORTICOSTERONE; TRACAZOLATE; 4 AMINOBUTYRIC ACID; DEOXYCORTICOSTERONE; DRUG DERIVATIVE; ISOPROTEIN; PROTEIN SUBUNIT; PYRAZOLE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; MUTATIONAL ANALYSIS; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; TEMPERATURE DEPENDENCE; XENOPUS LAEVIS; ANIMAL; DOSE RESPONSE; DRUG EFFECT; ELECTROPHYSIOLOGY; GENE EXPRESSION; METABOLISM; PATCH CLAMP; RAT;

ANIMALS; DESOXYCORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; OOCYTES; PATCH-CLAMP TECHNIQUES; PROTEIN ISOFORMS; PROTEIN SUBUNITS; PYRAZOLES; RATS; RECEPTORS, GABA-A; XENOPUS LAEVIS;

EID: 40149107738     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707665     Document Type: Article

References (74)

1. Adkins CE, Pillai GV, Kerby J, Bonnert TP, Haldon C, McKernan RM et al. (2001). α 4 β 3 δ GABA A receptors characterized by fluorescence resonance energy transfer‐derived measurements of membrane potential. J Biol Chem 276: 38934–38939.
2. Akk G, Bracamontes J, Steinbach JH (2001). Pregnenolone sulfate block of GABA A receptors: mechanism and involvement of a residue in the M2 region of the α subunit. J Physiol 532: 673–684.
3. Akk G, Bracamontes J, Steinbach JH (2004a). Activation of GABA A receptors containing the α4 subunit by GABA and pentobarbital. J Physiol 556: 387–399.
4. Akk G, Bracamontes JR, Covey DF, Evers A, Dao T, Steinbach JH (2004b). Neuroactive steroids have multiple actions to potentiate GABA A receptors. J Physiol 558: 59–74.
5. Akk G, Shu HJ, Wang C, Steinbach JH, Zorumski CF, Covey DF et al. (2005). Neurosteroid access to the GABA A receptor. J Neurosci 25: 11605–11613.
6. Amin JA, Weiss DS (1993). GABA A receptor needs two homologous domains of the β‐subunit for activation by GABA but not by pentobarbital. Nature 366: 565–569.
7. Amin J, Weiss DS (1994). Homomeric ρ 1 GABA channels: activation properties and domains. Receptors Channels 2: 227–236.
8. Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G et al. (1998). International Union of Pharmacology. XV. Subtypes of γ‐aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50: 291–313.
9. Barnes DM, White WF, Dichter MA (1983). Etazolate (SQ20009): electrophysiology and effects on [ 3 H]flunitrazepam binding in cultured cortical neurons. J Neurosci 3: 762–772.
10. Belelli D, Casula A, Ling A, Lambert JJ (2002). The influence of subunit composition on the interaction of neurosteroids with GABA A receptors. Neuropharmacology 43: 651–661.
11. Benke D, Mertens S, Trzeciak A, Gillessen D, Mohler H (1991). Identification and immunohistochemical mapping of GABA A receptor subtypes containing the δ‐subunit in rat brain. FEBS Lett 283: 145–149.
12. Bianchi MT, Haas KF, Macdonald RL (2002). α1 and α6 subunits specify distinct desensitization, deactivation and neurosteroid modulation of GABA A receptors containing the δ subunit. Neuropharmacology 43: 492–502.
13. Bianchi MT, Macdonald RL (2001). Mutation of the 9′ leucine in the GABA A receptor γ2L subunit produces an apparent decrease in desensitization by stabilizing open states without altering desensitized states. Neuropharmacology 41: 737–744.
14. Bianchi MT, Macdonald RL (2003). Neurosteroids shift partial agonist activation of GABA A receptor channels from low‐ to high‐efficacy gating patterns. J Neurosci 23: 10934–10943.
15. Bitran D, Hilvers RJ, Kellogg CK (1991). Anxiolytic effects of 3 α‐hydroxy‐5α[β]‐pregnan‐20‐one: endogenous metabolites of progesterone that are active at the GABA A receptor. Brain Res 561: 157–161.
16. Brickley SG, Revilla V, Cull‐Candy SG, Wisden W, Farrant M (2001). Adaptive regulation of neuronal excitability by a voltage‐independent potassium conductance. Nature 409: 88–92.
17. Brown N, Kerby J, Bonnert TP, Whiting PJ, Wafford KA (2002). Pharmacological characterization of a novel cell line expressing human α 4 β 3 δ GABA A receptors. Br J Pharmacol 136: 965–974.
18. Campo‐Soria C, Chang Y, Weiss DS (2006). Mechanism of action of benzodiazepines on GABA A receptors. Br J Pharmacol 148: 984–990.
19. Chang Y, Wang R, Barot S, Weiss DS (1996). Stoichiometry of a recombinant GABAA receptor. J Neurosci 16: 5415–5424.
20. Chang Y, Weiss DS (1999). Allosteric activation mechanism of the α1β2γ2 γ‐aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine. Biophys J 77: 2542–2551.
21. Crawley JN, Glowa JR, Majewska MD, Paul SM (1986). Anxiolytic activity of an endogenous adrenal steroid. Brain Res 398: 382–385.
22. Dibbens LM, Feng HJ, Richards MC, Harkin LA, Hodgson BL, Scott D et al. (2004). GABRD encoding a protein for extra‐ or peri‐synaptic GABA A receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet 13: 1315–1319.
23. Feng HJ, Macdonald RL (2004a). Multiple actions of propofol on αβγ and αβδ GABA A receptors. Mol Pharmacol 66: 1517–1524.
24. Feng HJ, Macdonald RL (2004b). Proton modulation of α1β3δ GABA A receptor channel gating and desensitization. J Neurophysiol 92: 1577–1585.
25. Fisher JL, Macdonald RL (1997). Single channel properties of recombinant GABA A receptors containing γ2 or delta subtypes expressed with α 1 and β 3 subtypes in mouse L929 cells. J Physiol 505 (Part 2): 283–297.
26. Fritschy JM, Mohler H (1995). GABA A ‐receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 359: 154–194.
27. Glykys J, Peng Z, Chandra D, Homanics GE, Houser CR, Mody I (2007). A new naturally occurring GABA A receptor subunit partnership with high sensitivity to ethanol. Nat Neurosci 10: 40–48.
28. Hevers W, Luddens H (1998). The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol Neurobiol 18: 35–86.
29. Hosie AM, Wilkins ME, da Silva HM, Smart TG (2006). Endogenous neurosteroids regulate GABA A receptors through two discrete transmembrane sites. Nature 444: 486–489.
30. Hosie AM, Wilkins ME, Smart TG (2007). Neurosteroid binding sites on GABA A receptors. Pharmacol Ther 116: 7–19.
31. Jones A, Korpi ER, McKernan RM, Pelz R, Nusser Z, Makela R et al. (1997). Ligand‐gated ion channel subunit partnerships: GABA A receptor α 6 subunit gene inactivation inhibits δ subunit expression. J Neurosci 17: 1350–1362.
32. Kokate TG, Svensson BE, Rogawski MA (1994). Anticonvulsant activity of neurosteroids: correlation with γ‐aminobutyric acid‐evoked chloride current potentiation. J Pharmacol Exp Ther 270: 1223–1229.
33. Lambert JJ, Belelli D, Hill‐Venning C, Peters JA (1995). Neurosteroids and GABA A receptor function. Trends Pharmacol Sci 16: 295–303.
34. Laurie DJ, Seeburg PH, Wisden W (1992). The distribution of 13 GABA A receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. J Neurosci 12: 1063–1076.
35. Lerma J, Herranz AS, Herreras O, Abraira V, Martin del Rio R (1986). In vivo determination of extracellular concentration of amino acids in the rat hippocampus. A method based on brain dialysis and computerized analysis. Brain Res 384: 145–155.
36. Liman ER, Tytgat J, Hess P (1992). Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs. Neuron 9: 861–871.
37. Macdonald RL, Gallagher MJ, Feng HJ, Kang J (2004). GABA A receptor epilepsy mutations. Biochem Pharmacol 68: 1497–1506.
38. Macdonald RL, Olsen RW (1994). GABA A receptor channels. Annu Rev Neurosci 17: 569–602.
39. Mangan PS, Sun C, Carpenter M, Goodkin HP, Sieghart W, Kapur J (2005). Cultured hippocampal pyramidal neurons express two kinds of GABA A receptors. Mol Pharmacol 67: 775–788.
40. McKernan RM, Whiting PJ (1996). Which GABA A ‐receptor subtypes really occur in the brain Trends Neurosci 19: 139–143.
41. Mertens S, Benke D, Mohler H (1993). GABA A receptor populations with novel subunit combinations and drug binding profiles identified in brain by α5‐ and δ‐subunit‐specific immunopurification. J Biol Chem 268: 5965–5973.
42. Mihalek RM, Banerjee PK, Korpi ER, Quinlan JJ, Firestone LL, Mi ZP et al. (1999). Attenuated sensitivity to neuroactive steroids in γ‐aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci USA 96: 12905–12910.
43. Mody I (2004). Another “tonic” in the realm of epilepsy. Epilepsy Curr 4: 248–249.
44. Morris KD, Amin J (2004). Insight into the mechanism of action of neuroactive steroids. Mol Pharmacol 66: 56–69.
45. Mortensen M, Smart TG (2006). Extrasynaptic αβ subunit GABA A receptors on rat hippocampal pyramidal neurons. J Physiol 577: 841–856.
46. Mostallino MC, Mura ML, Maciocco E, Murru L, Sanna E, Biggio G (2006). Changes in expression of the δ subunit of the GABA A receptor and in receptor function induced by progesterone exposure and withdrawal. J Neurochem 99: 321–332.
47. Mtchedlishvili Z, Kapur J (2006). High‐affinity, slowly desensitizing GABA A receptors mediate tonic inhibition in hippocampal dentate granule cells. Mol Pharmacol 69: 564–575.
48. Orser BA (2006). Extrasynaptic GABA A receptors are critical targets for sedative–hypnotic drugs. J Clin Sleep Med 2: S12–S18.
49. Patel JB, Malick JB, Salama AI, Goldberg ME (1985). Pharmacology of pyrazolopyridines. Pharmacol Biochem Behav 23: 675–680.
50. Peng Z, Hauer B, Mihalek RM, Homanics GE, Sieghart W, Olsen RW et al. (2002). GABA A receptor changes in δ subunit‐deficient mice: altered expression of α4 and γ2 subunits in the forebrain. J Comp Neurol 446: 179–197.
51. Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G (2000). GABA A receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101: 815–850.
52. Poltl A, Hauer B, Fuchs K, Tretter V, Sieghart W (2003). Subunit composition and quantitative importance of GABA A receptor subtypes in the cerebellum of mouse and rat. J Neurochem 87: 1444–1455.
53. Reddy DS (2003). Is there a physiological role for the neurosteroid THDOC in stress‐sensitive conditions Trends Pharmacol Sci 24: 103–106.
54. Rusch D, Zhong H, Forman SA (2004). Gating allosterism at a single class of etomidate sites on α1β 2 γ 2L GABA A receptors accounts for both direct activation and agonist modulation. J Biol Chem 279: 20982–20992.
55. Sanna E, Murgia A, Casula A, Biggio G (1997). Differential subunit dependence of the actions of the general anesthetics alphaxalone and etomidate at γ‐aminobutyric acid type A receptors expressed in Xenopus laevis oocytes. Mol Pharmacol 51: 484–490.
56. Saxena NC, Macdonald RL (1996). Properties of putative cerebellar γ‐aminobutyric acid A receptor isoforms. Mol Pharmacol 49: 567–579.
57. Sieghart W (1995). Structure and pharmacology of γ‐aminobutyric acid A receptor subtypes. Pharmacol Rev 47: 181–234.
58. Sieghart W, Sperk G (2002). Subunit composition, distribution and function of GABA A receptor subtypes. Curr Top Med Chem 2: 795–816.
59. Sperk G, Schwarzer C, Tsunashima K, Fuchs K, Sieghart W (1997). GABA A receptor subunits in the rat hippocampus I: immunocytochemical distribution of 13 subunits. Neuroscience 80: 987–1000.
60. Spigelman I, Li Z, Banerjee PK, Mihalek RM, Homanics GE, Olsen RW (2002). Behavior and physiology of mice lacking the GABA A ‐receptor δ subunit. Epilepsia 43 (Suppl 5): 3–8.
61. Stell BM, Brickley SG, Tang CY, Farrant M, Mody I (2003). Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by δ subunit‐containing GABA A receptors. Proc Natl Acad Sci USA 100: 14439–14444.
62. Storustovu SI, Ebert B (2006). Pharmacological characterization of agonists at δ‐containing GABA A receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of γ 2. J Pharmacol Exp Ther 316: 1351–1359.
63. Sundstrom‐Poromaa I, Smith DH, Gong QH, Sabado TN, Li X, Light A et al. (2002). Hormonally regulated α 4 β 2 δ GABA A receptors are a target for alcohol. Nat Neurosci 5: 721–722.
64. Thompson CL, Pollard S, Stephenson FA (1996). Developmental regulation of expression of GABAA receptor α 1 and α 6 subunits in cultured rat cerebellar granule cells. Neuropharmacology 35: 1337–1346.
65. Thompson SA, Wingrove PB, Connelly L, Whiting PJ, Wafford KA (2002). Tracazolate reveals a novel type of allosteric interaction with recombinant γ‐aminobutyric acid A receptors. Mol Pharmacol 61: 861–869.
66. Twyman RE, Macdonald RL (1992). Neurosteroid regulation of GABA A receptor single‐channel kinetic properties of mouse spinal cord neurons in culture. J Physiol 456: 215–245.
67. Ueno S, Tsutsui M, Toyohira Y, Minami K, Yanagihara N (2004). Sites of positive allosteric modulation by neurosteroids on ionotropic γ‐aminobutyric acid receptor subunits. FEBS Lett 566: 213–217.
68. Wallner M, Hanchar HJ, Olsen RW (2003). Ethanol enhances α 4 β 3 δ and α 6 β 3 δγ‐aminobutyric acid type A receptors at low concentrations known to affect humans. Proc Natl Acad Sci USA 100: 15218–15223.
69. Wardell B, Marik PS, Piper D, Rutar T, Jorgensen EM, Bamber BA (2006). Residues in the first transmembrane domain of the Caenorhabditis elegans GABA A receptor confer sensitivity to the neurosteroid pregnenolone sulfate. Br J Pharmacol 148: 162–172.
70. Winsky‐Sommerer R, Vyazovskiy VV, Homanics GE, Tobler I (2007). The EEG effects of THIP (Gaboxadol) on sleep and waking are mediated by the GABA A δ‐subunit‐containing receptors. Eur J Neurosci 25: 1893–1899.
71. Wisden W, Laurie DJ, Monyer H, Seeburg PH (1992). The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12: 1040–1062.
72. Wohlfarth KM, Bianchi MT, Macdonald RL (2002). Enhanced neurosteroid potentiation of ternary GABA A receptors containing the δ subunit. J Neurosci 22: 1541–1549.
73. Yang P, Jones BL, Henderson LP (2005). Role of the α subunit in the modulation of GABA A receptors by anabolic androgenic steroids. Neuropharmacology 49: 300–316.
74. Young R, Urbancic A, Emrey TA, Hall PC, Metcalf G (1987). Behavioral effects of several new anxiolytics and putative anxiolytics. Eur J Pharmacol 143: 361–371.